Regeneron’s stock climbs 4% as analyst look past earnings miss to focus on pipeline 0 02.05.2024 20:49 MarketWatch.com Regeneron Pharmaceuticals’ stock reversed early losses to trade higher on Thursday, as analysts looked beyond a first-quarter earnings miss to focus on some of the biotech’s pipeline products. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
